Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dubsky

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Clinical & Experimental Metastasis|August 26, 2015
Activity of T-DM1 in Her2-positive breast cancer brain metastasesRupert Bartsch, Anna S Berghoff, Ursula Vogl, et al.
Cancer Treatment Reviews|February 5, 2023
Germline TP53 pathogenic variants and breast cancer: A narrative reviewEva Blondeaux, Luca Arecco, Kevin Punie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trialGeorg Pfeiler, Robert Königsberg, Christian Fesl, et al.
Breast Care (Basel, Switzerland)|March 12, 2015
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast CancerElisabeth Bergen, Anna S Berghoff, Margaretha Rudas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapyPeter Dubsky, Paul Sevelda, Raimund Jakesz, et al.
Annals of Surgical Oncology|March 5, 2019
Prospective Evaluation of Residual Breast Tissue After Skin- or Nipple-Sparing Mastectomy: Results of the SKINI-TrialBärbel Papassotiropoulos, Uwe Güth, Federica Chiesa, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 8, 2022
Humor in radiological breast cancer screening: a way of improving patient service?Elisabeth Sartoretti, Thomas Sartoretti, Dow Mu Koh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8Martin Filipits, Margaretha Rudas, Verena Kainz, et al.
BMC Cancer|October 9, 2012
Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis testRalf Kronenwett, Kerstin Bohmann, Judith Prinzler, et al.
The Lancet. Oncology|June 7, 2011
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trialMichael Gnant, Brigitte Mlineritsch, Herbert Stoeger, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Clinical & Experimental Metastasis|August 26, 2015
Activity of T-DM1 in Her2-positive breast cancer brain metastasesRupert Bartsch, Anna S Berghoff, Ursula Vogl, et al.
Cancer Treatment Reviews|February 5, 2023
Germline TP53 pathogenic variants and breast cancer: A narrative reviewEva Blondeaux, Luca Arecco, Kevin Punie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trialGeorg Pfeiler, Robert Königsberg, Christian Fesl, et al.
Breast Care (Basel, Switzerland)|March 12, 2015
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast CancerElisabeth Bergen, Anna S Berghoff, Margaretha Rudas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapyPeter Dubsky, Paul Sevelda, Raimund Jakesz, et al.
Annals of Surgical Oncology|March 5, 2019
Prospective Evaluation of Residual Breast Tissue After Skin- or Nipple-Sparing Mastectomy: Results of the SKINI-TrialBärbel Papassotiropoulos, Uwe Güth, Federica Chiesa, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 8, 2022
Humor in radiological breast cancer screening: a way of improving patient service?Elisabeth Sartoretti, Thomas Sartoretti, Dow Mu Koh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8Martin Filipits, Margaretha Rudas, Verena Kainz, et al.
BMC Cancer|October 9, 2012
Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis testRalf Kronenwett, Kerstin Bohmann, Judith Prinzler, et al.
The Lancet. Oncology|June 7, 2011
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trialMichael Gnant, Brigitte Mlineritsch, Herbert Stoeger, et al.
Pageof 10